Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia

Blood

Volumn 97, Issue 2, 2001, Pages 509-515

  Auer, Rebecca L ^b   Jones, Christopher ^b   Mullenbach, Roman A ^b   Syndercombe Court, Denise ^b   Milligan, Donald W ^b   Fegan, Christopher D ^b   Cotter, Finbarr E ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; TRINUCLEOTIDE;

ARTICLE; CHROMOSOME 11; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME FRAGILE SITE; CHROMOSOME REPLICATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; GENE LOCATION; GENETIC STABILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; TRINUCLEOTIDE REPEAT;

EID: 0035863895     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.2.509     Document Type: Article

References (62)

1. The genetics of familial leukemia
2. Anticipation in familial chronic lymphocytic leukaemia
3. Simple tandem DNA repeats and human genetic disease
4. Trinucleotide repeats not the only cause of anticipation
5. Anticipation in familial chronic lymphocytic leukemia
6. Karyotypic evolution in CLL: Identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease
7. Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival
8. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis
9. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders
10. Discontinuous deletions at 11q23 in B cell chronic lymphocytic leukemia
11. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia
12. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia
13. ATM mutations in B-cell chronic lymphocytic leukemia
14. Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma
15. Molecular characterization of deletion at 11 q22.1-23.3 in mantle cell lymphoma
16. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma
17. Inversion of chromosome 11 inv(11)(p15q22) as a recurring chromosomal aberration associated with de novo and secondary myeloid malignancies: Identification of a P1 clone spanning the 11q22 breakpoint
18. A human gene (DDX10) encoding a putative DEAD box RNA helicase at 11q22-q23
19. The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX1O
20. Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer
21. Allelifc deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers
22. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: Identification of three independent regions
23. Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma
24. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach
25. Allelic deletion at 11q23.3-q25 is an early event in cervical neoplasia
26. Mismatch repair defects in human carcinogenesis
27. Microsatellite instability in inherited and sporadic neoplasms
28. Frequent clonal loss of heterozygosity but scarcity of microsatellite instability at chromosomal breakpoint cluster regions in adult leukemias
29. Trinucleotide repeat expansion and human disease
30. The fragile X site in somatic cell hybrids: An approach for molecular cloning of fragile sites
31. Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2
32. Characterization of the BCR promoter in Philadelphia chromosome-positive and -negative cell lines
33. Structure of the leukemia-associated human CBFB gene
34. Spontaneous breakage and fragile site expression in chronic lymphocytic leukemia
35. Localization of Jacobsen syndrome breakpoints on a 4O-Mb physical map of distal chromosome 11q
36. Co-localisation of CCG-repeats and chromosome deletion breakpoints in Jacobsen syndrome: Evidence for a common mechanism of chromosome breakage
37. Molecular Cloning: A Laboratory Manual
38. A new bacteriophage P1-derived vector for the propagation of large human DNA fragments
39. A novel rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones
40. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome
41. Most Jacobsen syndrome deletion breakpoints occur distal to FRA11B
42. Chromosome aberrations in B-cell chronic lymphocytic leukemia: Reassessment based on molecular cytogenetic analysis
43. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy
44. Human genes containing potymorphic trinucleotide repeats
45. Ataxia telangiectasia gene mutations and chronic lymphocytic leukaemia
46. Chromosomal fragile sites and cancer-specific breakpoints: A moderating viewpoint
47. The fragile site hypothesis of cancer
48. Fragile sites and cancer breakpoints: The pessimistic view
49. Deletion of the short arm of chromosome 3 in breast tumors
50. Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines
51. Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors
52. Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas
53. FISH mapping of YAC clones at human chromosomal band 7q31.2: Identification of YACS spanning FRA7G within the common region of LOH in breast and prostate cancer
54. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer
55. Integrated YAC contig containing the 3p14.2 hereditary renal carcinoma 3;8 translocation breakpoint and the fragile site FRA3B
56. A variable domain of delayed replication in FRAXA fragile X chromosomes: X inactivation-like spread of late replication
57. Association of fragile X syndrome with delayed replication of the FMR1 gene
58. Large domains of apparent delayed replication timing associated with triplet repeat expansion at FRAXA and FRAXE
59. Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: Implications for the mechanism of fragile site induction